![]() LadRx LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer. | ![]() Rasna Therapeutics Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia. | ![]() Repertoire Immune Medicines Repertoire Immune Medicines is a biotechnology company tapping the curative powers of the immune system to prevent, treat, or cure cancer, autoimmune conditions, and infectious diseases. | ||
Founding Date | Founding Date 2004 | Founding Date 1985 | Founding Date 2013 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US | Locations Los Angeles, US HQ | Locations New York, US HQ Greater London, GB Doylestown, US | Locations Cambridge, US HQ Schlieren, CH Cambridge, US |
Employees | Employees 194362% increase | Employees 385% decrease | Employees N/A | Employees 887% increase |
Valuation ($) | Valuation ($) 515.9 m | Valuation ($) 901.1 k | Valuation ($) 3.1 m | Valuation ($) N/A |
Financial | ||||
Net income | Net income ($153.5m) (FY, 2025) | Net income ($1.6m) (FY, 2024) | Net income ($4.4m) (FY, 2023) | Net income N/A |

LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer.
View company
Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia.
View company
Repertoire Immune Medicines is a biotechnology company tapping the curative powers of the immune system to prevent, treat, or cure cancer, autoimmune conditions, and infectious diseases.
View company